By contrast, collagen IV coating did not affect ER+ and HER2+ cell lines.<h4>Conclusions</h4>Abundance of stromal collagen IV increases risk of dying in breast cancer after DCIS, and collagen IV can promote cell motility in vitro. This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.